Hyloris Enrolls First Patient in Phase 3 Clinical Trial for
Innovative oral care solution aims to benefit patients taking blood thinning medications, who have an increased risk of prolonged bleeding ...
Read moreInnovative oral care solution aims to benefit patients taking blood thinning medications, who have an increased risk of prolonged bleeding ...
Read moreOver 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study LEVEL is a randomized, controlled Phase ...
Read moreOBT, in collaboration with GORTEC, is evaluating OBT076, an innovative Antibody Drug Conjugate (ADC) targeting CD205 receptor that is highly ...
Read moreSOUTH JORDAN, Utah, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and ...
Read moreVenice, FL, USA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTC:LVCE), a prominent leader in telehealth and remote patient ...
Read moreThe 7-peptide formulation of ELI-002 is designed to stimulate an immune response against seven KRAS mutations that drive 25% of ...
Read moreInitiation of REVEAL pediatric trial in the U.S. broadens the clinical evaluation of TSHA-102 to female patients 5-8 years old ...
Read moreNKGen Biotech’s autologous clinical program product candidate, SNK01, demonstrated improvement in neuroinflammation and cognitive function in patients with Alzheimer’s Disease ...
Read moreNAUTILUS is the first and only pivotal clinical study to evaluate neuromodulation therapy for treating drug refractory idiopathic generalized epilepsy ...
Read moreFirst patient dosed in Australia where 3 clinical trial sites have been activated.The trial will enrol advanced colorectal cancer patients ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.